NCT02176642View on ClinicalTrials.gov

Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence.

PHASE4TerminatedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 21, 2016

Study Completion Date

November 21, 2016

Conditions
Urinary Urge Incontinence
Interventions
DRUG

Oxybutynin extended release

5mg tablet taken by mouth daily for 6 weeks

DEVICE

Posterior Tibial Nerve Stimulation

In office therapy administered for 30 minutes once every week for a total of 6 weeks

DRUG

Placebo

Tablet taken by mouth daily for 6 weeks

Trial Locations (2)

27607

Duke OB/GYN Consultants of Raleigh, Raleigh

27707

Duke Urogynecology, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction

OTHER

lead

Duke University

OTHER

NCT02176642 - Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence. | Biotech Hunter | Biotech Hunter